MYCN and neoplasm: To further improve the prognostic accuracy, the inclusion of several gene expression-based risk estimation scores, integrating several prognostic determinants, such as age, tumor stage, and MYCN oncogene amplification, may be a useful addition to the INSS stage and COG risk stratification.